Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-25 @ 1:26 PM
NCT ID: NCT04391959
Description: None
Frequency Threshold: 0
Time Frame: 3 months
Study: NCT04391959
Study Brief: Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AZR-MD-001 Active AZR-MD-001 Active will be dosed up to twice weekly. AZR-MD-001 Active: AZR-MD-001 is an active ophthalmic ointment 1 None 1 15 8 15 View
AZR-MD-001 Vehicle AZR-MD-001 Vehicle will be dosed up to twice weekly. AZR-MD-001 Vehicle: AZR-MD-001 is a vehicle ophthalmic ointment 0 None 0 16 2 16 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
dysuria NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 23.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Eye irritation NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Conjunctival hyperaemia NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Dry eye NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Eye pain NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Eye pruritus NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Foreign body sensation NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Ocular discomfort NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Photophobia NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View
Vision blurred NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 23.0 View